MVMonika Vyas

Monika Vyas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Monika Vyas has a total of 233 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnosis of infectious disease pathology on whole slide images: a multi‐platform evaluation with implications for digital laboratory practice

    by Nandan Padmanabha, Quinn Rainer, Kanchan Kantekure, Paul A. VanderLaan, Yue Sun, Hemant Varma, Vikram Deshpande, Yuho Ono, Yaileen D. Guzman‐Arocho, Rahul M. Jawale, et al.

    Purpose: Adoption of whole slide imaging (WSI) is accelerating across anatomic pathology practices, yet there is a lack of evidence guiding its use for infectious disease diagnoses. WSI systems usually operate at a maximum of 40X magnification without z‐plane depth, appropriately raising concerns about detecting microorganisms. Methods: We assembled a 15‐case panel (with immunohistochemistry [IHC]/special stains where indicated) spanning bacterial, viral, parasitic and fungal infections of various organ systems, including five organism‐negative ‘controls’. An infectious disease pathologist independently reviewed all glass slides to confirm the diagnoses. Eight board‐certified pathologists reviewed cases (blinded to diagnoses) scanned on one of four high‐throughput scanner platforms (Philips SG300, Hamamatsu S360, Pramana (Spectral HT2) and Leica GT450 designated A‐D (not in order), two pathologists/platform). As a control group, two additional pathologists reviewed the same cases on glass slides. Additionally, in an attempt to compare image quality among the four WSI platforms, 10 pathologists (blinded to the platform) rated image quality from side‐by‐side screenshots in 12 representative cases. Results: Aggregate diagnostic scores were: Scanner A: 78%, Scanner D: 71%, Scanner C: 69% and Scanner B: 65%, (mean 71%) vs. 79% for glass‐slide reviewers. Intra‐platform variability between the two pathologists on the same scanner (up to 23% on platform D) exceeded inter‐platform differences. WSI reviewers performed near‐equivalently to glass‐slide reviewers for large organisms (92% vs. 89%) but lower for small/low‐burden organisms (36% vs. 63%). Conclusions: Diagnostic performance on WSI for infectious disease pathology in this exploratory study varied primarily with organism size and burden, not by platform‐specific image quality differences. WSI is non‐inferior to glass for large organisms, but glass slide review may be superior for small (and low burden) organisms.

  • Ki67 proliferation indices in advanced jejunoileal well‐differentiated neuroendocrine tumours are most prognostic when evaluated in mesenteric tumour deposits

    by Monika Vyas, Wei Chen, Raul S Gonzalez

    Background: Ki67 proliferation indices are used for grading well‐differentiated neuroendocrine tumours (NETs). Selection of tissue for staining can be challenging, especially in jejunoileal NETs (JI‐NETs), which can be multifocal and produce multiple metastases. This study aimed to determine parameters for selecting the most prognostically appropriate tissue for Ki67 staining in JI‐NETs. Materials and Methods: We identified JI‐NETs with at least one nodal metastasis and/or mesenteric tumour deposit. For each, we recorded patient age and sex; size of largest primary tumour, nodal metastasis and/or deposit; AJCC staging; and patient outcome (recurrence and disease‐specific death). We stained the largest primary, node and deposit in each case for Ki67 (clone SP6, Biocare Medical CRM325, 1:50) and also assessed mitotic rates. We photographed hotspot areas on each Ki67 slide. Ki67 index was calculated for each photo using QuPath digital image analysis software after training using a random forest supervised classifier. Twenty cases underwent manual Ki67 counting to validate QuPath results. All variables were compared to patient outcomes using standard univariate and multivariate Cox proportional hazard regression ( α = 0.05). Results: Among 75 JI‐NETs from 42 female and 33 male patients (mean age 61 years), 71 had positive nodes and 47 had deposits. Mean sizes of the largest primary tumours, nodal metastases and deposits were 1.97, 1.28 and 2.0 cm. Mean Ki67 was 1.82 (largest primaries), 2.24 (largest nodes) and 2.08 (largest deposits). In 51 cases (68%), the Ki67 of a node or deposit was higher than the primary tumour. Twenty‐one tumours (28%) recurred, with median projected time to recurrence time of 108 months. Over a median overall follow‐up of 72 months, six patients (8%) died of disease. Tumour deposit Ki67 was the only factor associated with increased risk of progression on multivariate analysis (hazard ratio [HR] 1.22 for each 1.0% increase, 95% confidence interval [CI] 1.02–1.46, P = 0.032); primary and nodal Ki67 were not, nor was the highest Ki67 or the Ki67 of the largest focus within each case. No Ki67 indices were significantly relevant to overall survival on multivariate analysis, though largest tumour deposit size was (HR 1.51 for each 1.0 cm increase, 95% CI 1.08–2.11, P = 0.015). Conclusions: Tumour deposits appear to play a key role in the outcome of patients with JI‐NETs. For meaningful Ki67 evaluation of JI‐NETs, the largest tumour deposit should be stained, if available.

  • Open Access

    Artificial Intelligence in Digital Pathology for Prostate Cancer Detection: FDA Clearance and Real-World Implementation

    by Quinn Rainer, Yue Sun, Monika Vyas, Pavel Kopach, Dibson Gondim, Vidarshi Muthukumarana, Harshwardhan Thaker, Vikram Deshpande

    Artificial intelligence (AI) has emerged as a promising adjunct in surgical pathology, particularly in the diagnosis of prostate cancer, where variability in interpretation or missed cancer foci can significantly affect patient management. This review provides a concise, practice-oriented overview of the two Food and Drug Administration (FDA)-cleared AI tools for prostate biopsy interpretation: Paige Prostate Detect and Ibex Prostate Detect (formerly Galen Second Read). We examine their regulatory indications, diagnostic performance and integration requirements within digital pathology workflows. Emphasis is placed on real-world implementation considerations, including variation in technical inputs and the level at which data are analysed. We highlight less obvious risks, such as domain shift and the potential for inequitable performance in under-represented patient populations. Trade-offs between sensitivity and specificity, particularly in the context of AI-assisted pathologist assessments, are discussed using data from clinical validation studies. We also consider the variable impact of AI tools depending on the user’s expertise, noting enhanced diagnostic consistency for general pathologists. By highlighting both the opportunities and limitations of integrating AI into routine practice, we aim to provide pathologists with a pragmatic understanding of how these systems may influence diagnostic workflows and to emphasise that FDA clearance must be complemented by local validation as well as ongoing performance monitoring to ensure safe and equitable deployment.

  • Digital Ki-67 quantification in neuroendocrine tumours: comparing performance of camera-captured images and open-source platforms across imaging modalities

    by Nandan Padmanabha, Ruben Oganesyan, Laurie O’BRien, Debbie Li, Shaelyn Widener, Buthaina Hakamy, Osman Yilmaz, Laura C Collins, Vikram Deshpande, Raul S Gonzalez, et al.

    Aims: Accurate assessment of the Ki-67 proliferation index (PI) is essential for grading and prognostication of gastrointestinal well-differentiated neuroendocrine tumours (NETs). While manual counting (MC) of 500–2000 tumour cells remains the standard, digital image analysis (DIA) offers potential advantages in efficiency and reproducibility. We evaluated the comparability of open-source DIA platforms on camera-captured (CC) images and whole-slide images (WSI) for Ki-67 quantification. Methods: Ki-67 hotspot areas of 70 NETs were photographed using a microscope-mounted camera. PI was determined by MC (gold standard) and compared with automated counts in 68 cases (two excluded owing to high background staining) using QuPath (V.0.4.4). In a randomly selected subset of 20 cases, the same hotspot areas were analysed using ImageJ, ChatGPT V.4.0 (colour-based segmentation) and the IHCexpert.com platform. Additionally, WSI files of these 20 cases were imported into QuPath for DIA; PI of identical areas were compared against static images. Results: DIA using QuPath (on CC images) demonstrated excellent agreement with MC (intraclass correlation coefficient). Only one case showed grade reclassification (manual G1, 2.92%; DIA G2, 3.38%). In the subset analysis (n=20), comparable Ki-67 indices were observed across all digital platforms and between CC images and WSI. Grade switches from changes in Ki-67 PI were observed in two additional cases (G2 to G1 in IHCexpert.com group and G1 to G2 in ChatGPT group). Conclusions: Our findings offer the prospect of eliminating variability in the analysis of PI estimation. Of note, CC images yield results similar to WSI, supporting broader applicability in resource-limited practice settings.


  • Primary gallbladder carcinomas showing pancreatic acinar features in the absence of a pancreatic primary

    by Osman Yilmaz, Berk Kaan Aktaş, Nuray Tezcan, Vikram Deshpande, Volkan Adsay, Monika Vyas

    Aims: Acinar cell carcinoma (ACC) is a lineage‐specific carcinoma that occurs nearly exclusively in the pancreas. We report, to our knowledge, the first series of gallbladder carcinoma demonstrating extensive acinar differentiation in the absence of a pancreatic primary. Methods: Three gallbladder carcinomas with extensive acinar differentiation were identified from an international cohort. Clinical, radiologic, macroscopic, histologic, immunophenotypic and molecular features were reviewed. Results: All tumours lacked an associated pancreatic primary on imaging and clinical evaluation. Two tumours formed well‐demarcated mural nodules lacking an exophytic mucosal component, while one tumour was associated with wall thickening. The neoplasms showed mural‐based infiltrative lesions composed of nests and acinar structures of cells with amphophilic cytoplasm and prominent nucleoli. One tumour arose in association with high‐grade dysplasia and BCL10‐positive pyloric‐type glands. Two tumours showed pure acinar morphology, while one demonstrated a mixed acinar cell carcinoma and small‐cell carcinoma. Immunohistochemically, all tumours showed diffuse expression of trypsin, and two tumours showed diffuse BCL10 positivity. Molecular profiling revealed heterogeneous alterations including TP53 mutations in two cases, RB1 inactivation in the mixed tumour. Conclusions: Gallbladder carcinomas may rarely exhibit acinar differentiation that closely mirrors pancreatic ACC. Recognition of this phenotype expands the morphologic repertoire of gallbladder carcinomas.

  • Open Access

    Defining hotspot for estimation of Ki-67 proliferation index of neuroendocrine tumors: QuPath algorithm vs. manual assessment

    by Ruben Oganesyan, Osman Yilmaz, Yevgen Chornenkyy, Kanchan Kantekure, Yuho Ono, Buthania Hakamy, Nandan Padmanabha, Vikram Deshpande, Raul S. Gonzalez, Monika Vyas


  • Quo Vadis colorectal intramucosal adenocarcinoma?

    by Vikram Deshpande, Adrian C Bateman, Munita Bal, Runjan Chetty, Maurice B Loughrey, Jinru Shia, Michael Vieth, Monika Vyas, Yoh Zen

    The classification and clinical implications of colorectal intramucosal adenocarcinoma remain controversial. Given the increasing frequency of diagnosis through colorectal cancer screening programmes, a reassessment of terminology and its impacts is necessary. This paper critically examines the diagnostic criteria, biological behaviour and clinical consequences of labelling these lesions as colorectal intramucosal carcinoma. While intramucosal adenocarcinoma exhibits cytological and architectural atypia beyond high-grade dysplasia, it remains confined to the mucosa and has minimal metastatic potential, with rare documented exceptions. Conversely, the use of carcinoma terminology has been associated with potential overtreatment, including unnecessary surgical resection, increased patient anxiety and financial burdens such as insurance complications. We explore geographic variations in classification and analyse the impact of terminology shifts. We propose a standardised framework that restricts the term intramucosal adenocarcinoma to intramucosal lesions exhibiting tumour budding or poorly differentiated clusters, signet ring cells, desmoplasia, vascular invasion, mucinous differentiation or features of neuroendocrine carcinoma, while reclassifying adenomas with cribriform architecture and complex glands as high-grade dysplasia. This nomenclature shift aims to reduce overtreatment, align with current oncologic understanding and ensure optimal patient care and communication.

  • Composite gangliocytoma/neuroma and neuroendocrine tumour: a contemporary analysis of 71 cases shows risk factors for metastasis

    by Luiz M Nova‐Camacho, Changqing Ma, Ibrahim Abukhiran, Nuha Shaker, M‐Nasan Abdul Baki, Katrina Collins, Iván González, Timothy Chao, Zhaohai Yang, Monika Vyas, et al.

    Aims: To describe the clinicopathological features of composite gangliocytoma/neuroma and neuroendocrine tumour (CoGNET) and possible risk factors for nodal metastasis. Methods and results: We compiled a cohort of 71 cases from 19 institutions. Mean patient age was 58 years. Thirty‐eight (54%) patients were male. Most patients (65%) had symptoms, including abdominal pain (20%) and gastrointestinal bleeding (19%). Most cases (70%) were described as a subepithelial mass/nodule, and nearly half (45%) were located in the 2nd portion of the duodenum. Mean tumour size was 2.2 cm, and most (87%) were well‐circumscribed. Nearly all cases (96%) demonstrated all three histologic components, with the epithelioid component being the most predominant overall (mean 59%). All cases involved the submucosa, with 7 (10%) additionally involving the muscularis propria. Solid areas of ganglion‐like cells were identified in 16/69 (23%) cases, glandular structure formation in 15/70 (21%), lymphovascular invasion (LVI) in 6/70 (9%) cases, and perineural invasion and necrosis in one case each. Nodal metastasis was identified at diagnosis in 8 (11%) cases; increased age, increased size, LVI and muscularis propria involvement were all significantly associated with nodal disease ( P < 0.05). Follow‐up data were available for 68 patients (mean 47 months); nearly all were alive without disease, though one patient developed liver metastasis after 8 months and died of the disease after 63 months. Conclusions: This largest series of CoGNET to date demonstrates that approximately 10% of cases develop nodal metastases. Large tumour size, muscularis propria involvement, advanced patient age and LVI appear to be risk factors for nodal metastasis.